beta

You're viewing our new website - find out more

Publication - Report

Review of Access to New Medicines

Published: 14 Dec 2016
Part of:
Health and social care
ISBN:
9781786526939

An independent review to assess the impact of the new approach introduced in 2014 by Scottish Medicines Consortium (SMC).

60 page PDF

655.3kB

60 page PDF

655.3kB

Contents
Review of Access to New Medicines
10 Glossary

60 page PDF

655.3kB

10 Glossary

ABPI

Association of the British Pharmaceutical Industry

ADTC

Area Drug & Therapeutic Committee

BNF

British National Formulary

CMO

Chief Medical Officer

DAD

Detailed Advice Document

EAS

Early Access Schemes

EMA

European Medicines Agency

HIS

Healthcare Improvement Scotland

HTA

Health Technology Assessment

ICER

Incremental Cost Effectiveness Ratio

IPTR

Individual Patient Treatment Request

ISD

Information Services Division

MAS

Managed Access Scheme

NDC

New Drugs Committee

NICE

National Institute for Health and Care Excellence

NMF

New Medicines Fund

NSS

NHS National Services Scotland

PACE

Patient and Clinician Engagement

PACS

Peer Approved Clinical System

PAS

Patient Access Scheme

PASAG

Patient Access Schemes Assessment Group

PHI

Public Health Intelligence

PPRS

Pharmaceutical Price Regulation Scheme

QALY

Quality-Adjusted Life-Year

RCMF

Rare Conditions Medicines Fund

SHTG

Scottish Health Technology Group

SMC

Scottish Medicines Consortium

T&FG

Task and Finish Group

Contact